Oncology (Williston Park). 2014 Jan;28(1):45-53.
Heavy chain diseases are a family of rare, systemic syndromes typically associated with or representing a variant of a B-cell neoplasm. Their characteristic feature is production of a mutated immunoglobulin heavy chain incapable of either partnering with light chains in the formation of a full immunoglobulin molecule or of being degraded by the proteasome. The abnormal heavy chain is detected in urine and/or serum without an associated light chain, a pathognomonic finding. Depending on the subtype of the altered heavy chain, these conditions can be subclassified as alpha, gamma, or mu heavy chain disease. We discuss the clinical presentation; epidemiology; laboratory, radiologic, and pathologic features; and treatment options for each of the heavy chain diseases, emphasising the importance of an accurate pathologic diagnosis and correct interpretation of immunologic studies in their identification.
重链病是一组罕见的系统性综合征,通常与 B 细胞肿瘤的变异体或代表其相关。其特征是产生突变的免疫球蛋白重链,既不能与轻链形成完整的免疫球蛋白分子,也不能被蛋白酶体降解。异常重链在尿液和/或血清中被检测到,而无相关的轻链,这是一种特征性发现。根据异常重链的亚型,这些疾病可被细分 为α、γ 或μ重链病。我们讨论了每种重链病的临床表现、流行病学、实验室、影像学和病理学特征以及治疗选择,强调了准确的病理诊断和对免疫研究的正确解释在其识别中的重要性。